PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Clinical Trials Advisor

BioTrinity 2017 – Fascinating Update to Our Microbiome Panel Announced

Here at BioTrinity HQ we are working hard on shaping the agenda and ensuring our panel discussions are current, relevant and interesting. Whilst working o...
Continue Reading →
ERT Acquires Exco InTouch
News

ERT Acquires Exco InTouch

Combination delivers end-to-end eCOA, patient engagement and digital health solutions to better serve customers PHILADELPHIA – December 8, 2016 –– ERT, a leading pro...
Continue Reading →
Clinical Trials Advisor

Wickham Laboratories Expands Sterility Testing Facilities

Wickham Laboratories completes facility expansion for growing sterility department. Wickham Laboratories announces the expansion of our service offerings once again ...
Continue Reading →
News

Treatment of rare skin disorder by Amryt gets EUR 20 m backing from European Investment Bank’s first ever pharma loan in Ireland Lead asset, Episalvan, now fully funded for pivotal Phase 3 study

Sufferers of rare skin disorders will benefit from new treatment being developed by Amryt Pharma to be supported by the European Investment Bank’s first direct backi...
Continue Reading →
Clinical Trials Advisor

Published scientific data demonstrates Plasticell’s CombiCult® technology platform expands stem cells in umbilical cord blood

22 November 2016, Stevenage UK: Plasticell, the leader in high through-put technology to develop stem cell therapies in regenerative medicine, has announced the publ...
Continue Reading →
Clinical Trials Advisor

43.5% cashback for clinical trials in Adelaide, Australia

43.5% of clinical trial costs will be reimbursed in cash to eligible companies with an aggregated annual turnover of less than A$20 million. To find out more abo...
Continue Reading →
Clinical Trials Advisor

PHARM Connect Congress 2017

  Boost your business in 2017 by presenting your solutions to the top pharmaceutical and biotechnology decision makers in Central Eastern Europe! &nbs...
Continue Reading →
News

Quay Pharma to supply promising cancer drug for trial

  Quay Pharma has reached an agreement with Redx Pharma Plc to manufacture Redx’s breakthrough cancer treatment drug. The new Porcupine inhibitor (RXC004) ...
Continue Reading →
News

Aptar Stelmi will showcase PremiumCoat™, the alternative coated stopper for sensitive drugs, at CPhI India from November 21 to 23, in Mumbai, India

PremiumCoat™, the alternative coated stopper for sensitive drugs PremiumCoat™ is a novel range of elastomeric stoppers developed by Aptar Stelmi and based ...
Continue Reading →
Clinical Trials Advisor

Turkish Cargo strengthens its presence with the launch of freighter service to Chennai.

Along with its spectacular passenger growth, Turkish Airlines is also rapidly growing its cargo network and operations. In line with that growth, Turkish Cargo inaug...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026